Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Govt puts a FULL STOP...

    Govt puts a FULL STOP on E-pharmacies running without licences, directs necessary action

    Farhat NasimWritten by Farhat Nasim Published On 2019-12-05T12:55:19+05:30  |  Updated On 5 Dec 2019 12:55 PM IST

    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation's (CDSCO) recently issued orders to impose a ban on unlicensed platform-e-pharmacies, until the government finalises draft rules to regulate e-pharmacies are finalized and put in place.


    The order came through an order issued by Dr V G Somani, Drugs Controller General of India(DCGI) on November 28 2019, directing all states and Union Territories to prohibit the sale of drugs by online pharmacies as per the Delhi High Court order. The order further asked all drug regulators in states and Union Territories to take "necessary action" to enforce the court order.


    The court while hearing a PIL by Zaheer Ahmed in December 2018 had ordered the ban on the sale of illegal or unlicensed online sale of medicines till the government drafts rules to regulate e-pharmacies.


    In September, the government, in an affidavit submitted to Delhi High Court, said it is in the process of finalising the draft rules for regulating e-pharmacies after going through representations of all stakeholders.


    Ahmed, in his PIL, had said that the online illegal sale of medicines would lead to a drug epidemic, drug abuse and misuse of habit-forming and addictive drugs, report PTI.


    He also moved a contempt plea in April, contending that the e-pharmacies continue to "blatantly" violate the high court direction and the central government was not doing anything to stop it following which the court issued notices to the Centre and some e-pharmacies.


    In response, E-pharmacies in July told the Court that they do not require a license for the online sale of drugs and prescription medicines as they do not sell them, instead they are only delivering the medications akin to food-delivery app Swiggy.


    In the PIL, Ahmed also said since there was no mechanism to control the sale of medicines online, this puts health and lives of people at high risk and affects their right to a safe and healthy life under Article 21 of the Constitution.


    Ahmed claimed that the Ministry of Health, Central Drugs Standard Control Organisation and an expert committee appointed by the drug consultative committee have already concluded that the online sale of medicines is in contravention of the provisions of Drugs and Cosmetics Act, 1940 and the other allied laws.


    Also Read: Final regulations on e-pharmacy likely by December-end, says DCGI


    Still lakhs of drugs are being sold on internet every day, it said, adding that some of the drugs/medicines contain narcotic and psychotropic substances and some can even cause antibiotic resistant-bacteria which is a threat not only to the patient but to the humanity at large.


    As per a recent media report by Live Mint, despite the prohibitory orders to shut operations of selling drugs online, e-pharmacy firms claim that the move will hardly affect their business as their modus operandi is via licensed offline pharmacies.


    However, a large number of skilled professionals attached to the e-pharmacy business is likely to be impacted by the move more than the customers as the e-pharmacy sector is catering to around 50 lakh patients per month and is growing rapidly attracting further investments, reports TOI.


    Commenting on the move, senior executive from an e-pharmacy told Business Standard, "If the government decides to implement such a thing, we would definitely challenge it in the court of law. Moreover, if you follow this, then generating orders over phone calls or even through social media platforms like Whatsapp is not covered under the Drugs and Cosmetics Act, which is common practice for brick-and-mortar stores."


    Also Read: No online sale of drugs till regulatory rules in place: Delhi High Court

    ahmed pilCDSCOCentral Drugs Standard Control OrganisationconstitutionDCGIDelhi HCDept of healthdraft rulesDrugs and Cosmetics RulesDrugs Controller General of IndiaDrugs Technical Advisory BoardDTABe-pharmacyepharmaciesepharmacyeprescriptionHealthcareHigh Courtinternetinternet saleonline drug saleonline saleSwiggyVG Somani
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok